Back to Directory
Last Updated: 06/06/2026
Locate Bio
Nottingham
Founded 2001
Controlled-release orthobiologics for spinal fusion and bone repair
Locate Bio is a clinical-stage biotechnology company developing a portfolio of orthobiologic products for musculoskeletal surgery.
Its proprietary Programmed Drug Release platform encapsulates recombinant proteins within biodegradable polymer scaffolds to enable controlled, extended-release delivery.
Lead product LDGraft is an rhBMP-2 bone graft substitute in clinical trial for lumbar interbody fusion, having received FDA Breakthrough Device Designation.
The pipeline also includes synthetic bone graft substitutes and antibiotic-eluting scaffolds for osteomyelitis.
Company Notes
Previously Known As
RegenTec Limited
Member of